Experic Connects with Rare Disease Leaders at World Orphan Drug Congress
Experic recently participated in the World Orphan Drug Congress in Boston, a leading event dedicated to advancing therapies for rare and orphan diseases.
Representing Experic at the event were Brian Fagan, Vice President, Operations, and Matthew Sciscione, Director of Business Development, who engaged with sponsors, partners, and industry leaders to discuss the evolving needs of orphan drug development.
Throughout the event, conversations focused on the unique challenges of rare disease programs; including small patient populations, complex formulations, and the need for flexible, responsive manufacturing and clinical supply strategies. Experic’s integrated approach, spanning drug product development through clinical supply, enables sponsors to navigate these challenges with greater efficiency and confidence.
Interested in continuing the conversation?
Contact our team to learn how Experic can support your next program.